Roku is buying ad tech company Dataxu in $150 million deal

  • 📰 CNBC
  • ⏱ Reading Time:
  • 49 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 72%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Dataxu will boost Roku's advertising business.

Roku said it has entered into an agreement to buy Boston-based demand-side platform Dataxu.

Dataxu provides marketers with automated bidding and self-serve software to manage ad campaigns programmatically across digital platforms.is buying Dataxu, a platform that lets marketers plan and buy video ad campaigns, for $150 million in cash and stock. The deal was announced Tuesday morning. Boston-based Dataxu, a demand-side platform, provides marketers with automated bidding and self-serve software to manage ad campaigns programmatically across digital platforms.

"TV advertising is shifting toward OTT and a data-driven model focused on business outcomes for brands," Anthony Wood, Roku CEO, said in a statement. "The acquisition of Dataxu will accelerate our ad platform while also helping our content partners monetize their inventory even more effectively."Dataxu had hired investment bank GCA Advisors as it explored a potential sale. According to the report, Dataxu was initially seeking a valuation of around $300 million.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 12. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Drug companies reach $260 million opioid settlement with Ohio counties, averting landmark trialFour large drug companies reached a last-minute $260 million legal settlement ov... Calculated financial risks Headline's should say, US's crooked dick 'justice' system rape's pharmaceutical companies and makes people with chronic pain suffer. They used fear mongering and scare tactics to create unethical laws in healthcare to disrupt the market and give control to unethical drug dealers. And their still making more money than the railroad. Guess what? Guess why? If you buy from the opioid company’s you might not get fentanyl and die.
출처: Reuters - 🏆 2. / 97 더 많은 것을 읽으십시오 »

Peloton stock analysts initiate coverage, are overwhelmingly bullish - Business InsiderPeloton just got a slew of 'buy' ratings from analysts who think the bike company is poised for major growth and could turn profit within five years.
출처: BusinessInsider - 🏆 729. / 51 더 많은 것을 읽으십시오 »